Loading...

AJOONI Ajooni Biotech Ltd Other Situations Announcement

jn B

JN

Ajooni Biotech Ltd

(AJOONI)

2025 Announcement

Show Summary

Show Summary

Strong Q4 Results

No Fund Deviations

Financial Results Submitted

Board Meeting Results

Disclosure Submission

Regulatory Disclosure

Management Changes

Board Meeting Outcome

Convertible Warrants Withdr...

Board Meeting Outcome

Disclosure Submitted

Regulatory Submission

Cautionary Notice

Trading Window Closure

Financial Filing Update

Director Appointment Update

Financial Results Published

No Fund Variations

Board Meeting Outcome

Q4 Financial Results

Voting Results Disclosure

Convertible Warrants Issued

Scrutinizer's Report Submitted

Extraordinary General Meeting

Corrigendum Issued

Corrigendum Publication

Books Maintenance Change

300+ Dealers Appointed

Confirmation Certificate Su...

Investor Presentation

Extraordinary General Meeting

Extraordinary General Meeting

Convertible Warrants Offering

New Director Appointed

Board Meeting Outcomes

Trading Window Closure

Financial Results Clarifica...

Financial Results Submitted

Dairy Expo Participation

Strong Q2 Results

No Fund Deviation

Financial Results

Financial Results

Export Order Received

Repeat Order Received

Confirmation Certificate

Investor Presentation

Trading Window Closure

New Auditors Appointed

Annual General Meeting

BIS Certification Awarded

BIS Certification Received

Financial Results Submission

AGM Announcement

Annual General Meeting

Book Closure Notice

Board Meeting Outcomes

Statement of Deviation or V...

Financial Results Submission

Financial Results Approval

Expansion Plans

Cattle Feed Expansion

Confirmation Certificate Su...

Prestigious Order Received

Trading Window Closure

Strategic Partnership

Partnership Announcement

Rights Issue Update

Ajooni Biotech Land Acquisi...

Moringa Plantation

Rights Issue Approval

Transcript Availability

Moringa Project Launch

Investor Presentation

Investor Call Recording Link

Financial Performance

Financial Results

Statement of Deviation in F...

Financial Results Approval

Financial Results Submission

Ajooni Biotech Board Meetin...

Partnership Announcement

Advertisement Submission

Expansion Plans

Expansion Announcement

Investor Presentation

Rights Issue Approved

Letter of Offer Approval

Biotech Expansion

Right Issue Update

Upgrade & Rights Issue

Credit Rating Upgrade

Rights Issue Record Date Re...

Revised Rights Issue

Record Date Revision

Disclosure Submission

Disclosure Submission

Export Order Received

Connection with Avon Animal...

Partnership Agreement

Contract Agreement

Confirmation Certificate Fi...

Trading Window Closure

Revised Record Date

Rights Issue Outcome

Record Date Revision

Rights Issue Committee Meet...

Record Date Announcement

Rights Issue Record Date

Rights Issue Committee Outcome

Publication of Financial Re...

Deviation Statement

Appointment of Auditors

Financial Results Submission

Quarterly Earnings - Financ...

Functional Website

Confirmation Certificate Su...

Trading Window Closure

Right Issue Committee Meeti...

Financial Results Submission

Deviation Announcement

Trading Window Closure

Revised Voting Results

Amendment to AOA/MOA

Increase in Authorized Capital

Publication of Financial Re...

Board Meeting Outcome

Board Meeting Outcome

External Links:

Data:

Ajooni Biotech Limited reported that there are no deviations or variations in the utilization of proceeds from its Rights Issue of Rs. 42.31 crore for the quarter ended December 31, 2024, as reviewed by the Audit Committee and approved by the Board.

AI Assistant

Ajooni Biotech Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.